Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma

We aim to explore association between copy number alteration (CNA) and sensitivity to common tyrosine kinase inhibitors (TKIs) used in clear-cell renal cell carcinoma (ccRCC) treatment.

Source: Cancer Cell International - October 6, 2020 Category: Cancer & Oncology Authors: Liang Wang, Yuqing Li, Yinfeng Lyu, Hui Wen and Chenchen Feng Tags: Primary research Source Type: research